Chemoinformaics analysis of Phlogantholide-A
| Molecular Weight | 334.456 | nRot | 4 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 17 |
| Exact Molecular Weight | 334.214 | nRing | 3 |
| Solubility: LogS | -3.884 | nHRing | 1 |
| Solubility: LogP | 2.724 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 56.6118 |
| nHD | 2 | BPOL | 32.7002 |
| QED | 0.735 |
| Synth | 4.669 |
| Natural Product Likeliness | 2.698 |
| NR-PPAR-gamma | 0.077 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.01 |
| HIA | 0.021 |
| CACO-2 | -5.166 |
| MDCK | 0.00000753 |
| BBB | 0.596 |
| PPB | 0.927193 |
| VDSS | 1.699 |
| FU | 0.0642193 |
| CYP1A2-inh | 0.035 |
| CYP1A2-sub | 0.278 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.421 |
| CYP2c9-inh | 0.217 |
| CYP2c9-sub | 0.153 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.478 |
| CYP3a4-inh | 0.178 |
| CYP3a4-sub | 0.222 |
| CL | 16.386 |
| T12 | 0.472 |
| hERG | 0.007 |
| Ames | 0.02 |
| ROA | 0.729 |
| SkinSen | 0.104 |
| Carcinogencity | 0.265 |
| EI | 0.011 |
| Respiratory | 0.811 |
| NR-Aromatase | 0.114 |
| Antiviral | Yes |
| Prediction | 0.735844 |